Invesco arrives at its July 28 Q2 print with a wave of analyst upgrades at its back and options traders noticeably more hedged than they were just a week ago.
The analyst story is unusually one-directional ahead of this release. Across five separate actions in the past two weeks, every firm that moved a target moved it higher — RBC Capital lifted to $33 (from $31) on July 23, Barclays raised to $31 from $26, Morgan Stanley nudged to $30 from $29, and Evercore ISI moved to $32. None of these moves came with a rating upgrade; all four firms held their existing stances. That combination — rising targets, unchanged ratings — reflects a Street that acknowledges the stock's 11% rally over the past month but is not yet ready to call it a full re-rating. The consensus mean target of $31.58 sits only modestly above the current $29.93, leaving limited implied upside even after the target revisions.
Options traders have turned more defensive since the last article on this name. The put/call ratio has climbed to 0.233, roughly 1.5 standard deviations above its 20-day average of 0.178 — the highest reading in several weeks. That shift happened quickly: the PCR was below 0.15 for most of the first two weeks of July before jumping sharply around July 20. The move is notable, though context matters — the 52-week high is 0.40, so this is elevated caution, not alarm. Short interest tells a calmer story than it did ten days ago. The position has stabilised near 4.2% of the free float after its mid-July spike, with only fractional daily changes since July 10. Cost to borrow remains negligible at 0.47%, and borrow availability is extraordinarily loose at over 4,400% — meaning new shorts face no mechanical friction whatsoever if they choose to press the trade.
The bull case rests on momentum: the EPS momentum factor ranks in the 91st percentile over 30 days and the 86th over 90 days, and the stock has outrun most asset-management peers year-to-date despite trailing European names like DWS and Amundi. Bears point to the valuation ceiling — price-to-book below 1 and a PE near 9.9x reflect persistent fee-pressure concerns and questions about Invesco's active-versus-passive mix — and to the fact that the Street's most bullish firm, RBC, is still only at $33 on a stock that has already run to $30.
The July 28 print will test whether Q2 AUM flows and fee-rate trends justify the multiple expansion the stock has already priced in, or whether the target-raising cycle finds its ceiling at a number that leaves bulls with little margin for disappointment.
See the live data behind this article on ORTEX.
Open IVZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
